Tegaserod analytical method [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-04-08 13:23 (1476 d 15:44 ago) – Posting: # 21318
Views: 1,256

Hello colleagues
I hope you are in good health and conditions, and wish the the COVID-19 crisis come to end in all countries.
kindly we are developing an analytical method for Tegaserod in human plasma, if you have an experience with this product (6 mg dose), is the metabolite M29 need to be included to be detected and measured, and if an LLOQ of 50 pg/ml will be enough?

looking to hear your advises
Thank you

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
62 visitors (0 registered, 62 guests [including 7 identified bots]).
Forum time: 05:08 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5